Filed: Kyushu Electric's Missing Drive Holds 10.9M Records
Kyushu Electric's grid subsidiary lost a drive holding 10.9M customer records to a suspected theft, with METI demanding a full report by July 8.
Kyushu Electric's grid subsidiary lost a drive holding 10.9M customer records to a suspected theft, with METI demanding a full report by July 8.
Oracle's PeopleSoft zero-day hit 100+ organizations, 68% of them universities, with student finance records now on a hacking group's leak site.
A former employee silently accessed 34 million accounts while Coupang grew. The $412M Korean fine that just landed is only the start of the bill.
AudiA6 laundered $380M for ransomware gangs across three years. A Poland arrest unraveled a network that 11 countries couldn't crack alone.
Denis Obrezko charged for buying Void Blizzard's attack infrastructure; the FBI confirmed 11 U.S. company breaches, likely a fraction of the total.
FTC's restraining order against National Amendment Assistance exposes how CARES Act branding still lures distressed homeowners into foreclosure.
Biopharma cut nearly 7,000 jobs in May, a 47% YoY surge: Takeda's 4,500 restructuring targets 200B yen in savings, BioNTech another €500M.
A 93% AI confidence score isn't a match probability. Florida cops knew it, filed the warrant anyway, and jailed Robert Dillon for two months.
Munich's Regional Court ruled Google owns its AI Overviews speech, meaning it must pay when that speech defames publishers with invented facts.
ShinyHunters confirms breaching 300 Oracle PeopleSoft instances at 100+ organizations, with zero-days in play and universities hit first.
CFTC's prediction market rule proposes a categorical bar on war and terrorism bets, citing assassination-plot conflicts of interest.
Amazon's $17.5B delayed-draw loan carries a Sept. 30 draw deadline and zero financial covenants, built to fund a $200B AI capex push.
ServiceNow patched an open API silently on June 5, then disclosed attackers had queried customer tables four days later. Shares fell on disclosure.
Sanofi pulled the MOBILIZE phase 3 after an independent DMC found riliprubart unlikely to deliver, leaving $555M in projected CIDP sales at risk.
$38B Visa-Mastercard swipe fee deal gets preliminary court nod, but the NRF says the fee cut just rolls rates back to 2023 levels.